Iradimed Corp. (IRMD) Tops Q1 EPS by 3c; Boosts FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
IRADIMED CORPORATION Announces First Quarter 2016 Financial Results
April 29, 2016 7:00 AM EDTRevenue grows 28.2% compared to the same quarter last yearReports first quarter 2016 non-GAAP diluted EPS of $0.21Increases full year 2016 non-GAAP earnings guidanceAnnounces second quarter financial guidance
WINTER SPRINGS, Fla., April 29, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATIONÂ (NASDAQ: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended March 31, 2016.Â
For the first quarter ended March 31, 2016, the Company reported revenue of $9.0 million, an increase... More
